xRB as a modulator of transcription

被引:31
作者
Sellers, WR
Kaelin, WG
机构
[1] Dana-Farber Cancer Institute, Div. of Neoplastic Dis. Mechanisms, Harvard Medical School, Boston, MA 02115
来源
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 1996年 / 1288卷 / 01期
关键词
D O I
10.1016/0304-419X(96)00014-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
pRB interacts with a number of transcription factors and can both directly and indirectly modulate transcriptional activity. Growth suppression by pRB is tightly linked to its ability to form complexes with E2F which are capable of repressing transcription of certain genes required for S phase. The ability of pRB to enhance the activity of several non-E2F transcription factors might suggest a mechanism by which pRB could coordinately regulate sets of genes at or near the restriction point. Specifically, complexes consisting of underphosphorylated pRB and E2F, by virtue of transcriptional repression of promoters containing E2F sites, would act to block entry into S phase. At the same time, distinct complexes of underphosphorylated pRB and transcription factors such as the glucocorticoid receptor, ATF-2, or MyoD, might lead to an increase in the transcription of genes required for differentiation or for additional growth inhibitory functions (e.g. TGF-β1). Changes in the activities of various cyclin-dependent kinase complexes would lead to phosphorylation of pRB and thus coordinate a release of S phase genes from repression with a loss of activation of differentiation genes. While this model is speculative, the role of pRB as a transcriptional modulator, as well as its interactions with cell-cycle regulatory kinases, places it in a position to integrate extracellular and intracellular growth signals and to transduce those signals into changes in gene transcription which ultimately influence cell growth and differentiation.
引用
收藏
页码:M1 / M5
页数:5
相关论文
共 77 条
  • [1] TRANSCRIPTIONAL CONTROL BY E2F
    ADAMS, PD
    KAELIN, WG
    [J]. SEMINARS IN CANCER BIOLOGY, 1995, 6 (02) : 99 - 108
  • [2] THE RETINOBLASTOMA SUSCEPTIBILITY GENE-PRODUCT REPRESSES TRANSCRIPTION WHEN DIRECTLY BOUND TO THE PROMOTER
    ADNANE, J
    SHAO, ZH
    ROBBINS, PD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (15) : 8837 - 8843
  • [3] ADNANE J, 1995, ONCOGENE, V10, P381
  • [4] MAD-MAX TRANSCRIPTIONAL REPRESSION IS MEDIATED BY TERNARY COMPLEX-FORMATION WITH MAMMALIAN HOMOLOGS OF YEAST REPRESSOR SIN3
    AYER, DE
    LAWRENCE, QA
    EISENMAN, RN
    [J]. CELL, 1995, 80 (05) : 767 - 776
  • [5] A SWITCH FROM MYC-MAX TO MAD-MAX HETEROCOMPLEXES ACCOMPANIES MONOCYTE/MACROPHAGE DIFFERENTIATION
    AYER, DE
    EISENMAN, RN
    [J]. GENES & DEVELOPMENT, 1993, 7 (11) : 2110 - 2119
  • [6] ADENOVIRUS E1A PROTEINS CAN DISSOCIATE HETEROMERIC COMPLEXES INVOLVING THE E2F TRANSCRIPTION FACTOR - A NOVEL MECHANISM FOR E1A TRANSACTIVATION
    BAGCHI, S
    RAYCHAUDHURI, P
    NEVINS, JR
    [J]. CELL, 1990, 62 (04) : 659 - 669
  • [7] FUNCTIONAL SYNERGY BETWEEN DP-1 AND E2F-1 IN THE CELL CYCLE-REGULATING TRANSCRIPTION FACTOR DRTF1/E2F
    BANDARA, LR
    BUCK, VM
    ZAMANIAN, M
    JOHNSTON, LH
    LATHANGUE, NB
    [J]. EMBO JOURNAL, 1993, 12 (11) : 4317 - 4324
  • [8] E2F-4, A NEW MEMBER OF THE E2F GENE FAMILY, HAS ONCOGENIC ACTIVITY AND ASSOCIATES WITH P107 IN-VIVO
    BEIJERSBERGEN, RL
    KERKHOVEN, RM
    ZHU, LA
    CARLEE, L
    VOORHOEVE, PM
    BERNARDS, R
    [J]. GENES & DEVELOPMENT, 1994, 8 (22) : 2680 - 2690
  • [9] BREMNER R, 1995, MOL CELL BIOL, V15, P3256
  • [10] ACTIVITY OF RNA-POLYMERASE-I TRANSCRIPTION FACTOR UBF BLOCKED BY RB GENE-PRODUCT
    CAVANAUGH, AH
    HEMPEL, WM
    TAYLOR, LJ
    ROGALSKY, V
    TODOROV, G
    ROTHBLUM, LI
    [J]. NATURE, 1995, 374 (6518) : 177 - 180